Xylem’s YSI biochemistry analyzer is effective tool for cell culture and cancer research

The 2950 Biochemistry Analyzer from YSI, a Xylem brand, has proven to be an effective and efficient tool for cell culture applications in oncology research.

Xylem’s YSI brand will be exhibiting in booth 3417/3517 at Pittcon 2015, March 9-12, in New Orleans, Louisiana.

Specifically for oncology drug development applications, the YSI 2950 biochemistry analyzer is used to measure analytes such as glucose, glutamine, glutamate, lactate, providing a simple, automated analysis of bioprocess cell culture samples, with accurate results in less than a minute.

A recent paper published in Nature illustrated how pancreatic cancer researchers are using the YSI 2950 for measuring and monitoring glucose and lactate in tumor cell culture samples. The results of this analysis contributed to the important finding that the surviving dormant tumor cells have a decreased reliance on glycolysis for cellular energy and a stronger reliance on mitochondrial respiration. This makes the cells sensitive to oxidative phosphorylation inhibitors, which leads to possible treatment to prevent tumor recurrence.

To learn more about YSI please visit www.ysilifesciences.com. To also learn more about the complete range of analytics products from Xylem please visit www.xylemanalytics.com.

Source:

Xylem

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Survey reveals lack of awareness about pancreatic cancer risk among adults under age 50